Vibrio Infections Clinical Presentation

  • Author: Hoi Ho, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Aug 15, 2011
 

History

Vparahaemolyticus is the leading cause of seafood-associated gastroenteritis in the United States. Most individuals with noncholera Vibrio infections report recent consumption or handling of contaminated seafood such as oysters, clams, crabs, or other shellfish. Others have a history of contact with brackish or salty waters. Persons with immunodeficiency disorders, chronic liver disease, and iron storage disorders may be particularly susceptible to severe infections and have rapid clinical deterioration. With the exception of dramatic clinical progression in wound infection and septicemia, no characteristic signs and symptoms of early-stage noncholera Vibrio infections exist (see Table 3).

Table 3. Clinical Signs and Symptoms of Vibrio Infections (Open Table in a new window)

Clinical PresentationSymptoms (Frequency)
GastroenteritisDiarrhea (100%)



Abdominal cramps (89%)



Nausea (76%)



Vomiting (55%)



Fever (47%)



Bloody stools (29%)



Headache (24%)



Myalgia (24%)



Wound infectionSwelling (100%)



Pain (100%)



Erythema (100%)



Bullae (30-50%)



Necrosis (30-50%)



Gangrene (< 10%)



SepticemiaFever (>90%)



Hypothermia (< 10%)



Hypotension (100%)



Tachycardia (80-90%)



Shock (50-70%)



Bullae (80-100%)



Acute respiratory distress syndrome (< 5%)



Multiple organ dysfunction (30-50%)



While atypical infections with Vibrio species involving peritonitis, pneumonia, endometritis, meningitis, septic arthritis, osteomyelitis, and keratitis have been reported, in general, Vibrio causes 3 clinical symptoms: gastroenteritis, skin and soft tissue infections, and septicemia.

Gastroenteritis

After an average incubation period of 19 hours (range, 12-52 h), patients with Vibrio gastroenteritis report abdominal pain or cramps, nausea, vomiting diarrhea, fevers and chills.[21] Patients frequently pass several watery stools (10-15/d). The occurrence of bloody diarrhea varies. It is reported in 25% of patients with V parahaemolyticus infection but may develop in up to 75% of patients with V fluvialis infection.

Low-grade fever may be observed in patients with Vibrio gastroenteritis.

Most patients remain alert upon admission. However, elderly patients may have decreased mental status due to dehydration or sepsis. Death is rare, but would most likely be caused by concomitant Vibrio septicemia.

Skin and soft tissue infections

Patients frequently report injury associated with handling contaminated shellfish (preparation of St Peter's fish (Tilapia zillii); preparation of crabs, lobsters, or mussels), particularly fishhooks within the fish. Injuries can also be sustained when stepping on seashells, crustaceans, or stingrays.[22]

Initially, patients with such infections almost always report severe pain of the involved limb or body part. Numbness of the wound and the surrounding area may predominate if the patient has delayed seeking medical attention.

Septicemia

Symptoms usually occur within 7-14 days of contact. Patients frequently exhibit a dramatic clinical presentation of bacteremia, minus a clear focus. This may be characterized by the abrupt onset of the following:

  • High fever
  • Shaking chills
  • Generalized myalgia
  • Exquisite pain in the lower extremities (most characteristic) or, rarely, pain in the lower trunk[23]
Next

Physical

The physical findings of Vibrio infections vary according to clinical presentations.

  • Acute gastroenteritis
    • Patients with acute Vibrio gastroenteritis are typically acutely ill with diarrhea, nausea, vomiting, abdominal pain, and fever (50%).
    • The vital signs, such as blood pressure and heart rate, vary depending on the level of dehydration.
    • Unless the patient has underlying disease, no physical findings are specific for acute Vibrio gastroenteritis.[21]
  • Skin and soft tissue infection
    • After a short incubation period (3-24 h), patients with Vibrio wound infections frequently present with rapidly progressing wound swelling and severe pain.
    • The majority of such wounds involve the fingers, palms, or soles of the feet.
    • In milder cases, erythema, edema, and pain are localized to the initial wound, without signs of compartment syndrome, necrosis, gangrene, or necrotizing fasciitis.
    • In patients with medical conditions such as cirrhosis or malignancies, the wound infection may progress very rapidly, with formation of hemorrhagic bullae and extensive soft-tissue necrosis.[22, 23]
  • Septicemia
    • After a short incubation period (12-48 h) following the consumption of raw seafood or exposure of broken skin to warm seawater, patients with Vibrio septicemia frequently develop fever, shaking chills, generalized myalgia, edema, and severe pain in the lower extremities.[23]
    • Within 3-24 hours, edema of the lower extremities worsens.
    • Multiple hemorrhagic bullae and extensive ecchymossis distributed predominantly over the lower extremities form rapidly (see the images below). Vibrio infections. Early bullous lesions appear ovVibrio infections. Early bullous lesions appear over the dorsum of the foot of a patient with cirrhosis. Vibrio infections. In a patient with cirrhosis, skVibrio infections. In a patient with cirrhosis, skin lesion rapidly becomes necrotic. Vibrio infections. Bullous lesions in a patient wiVibrio infections. Bullous lesions in a patient with cirrhosis continue to progress, and the patient rapidly develops hypotension and shock despite aggressive medical therapy.
    • Patients frequently become hypotensive despite aggressive intravenous fluid therapy.
    • Patients become lethargic, obtunded, and, finally, unconscious as the disease progresses.
    • Oliguria may develop.
    • Noncardiogenic pulmonary edema may develop.
  • Peritonitis - Abdominal pain and cloudy peritoneal fluid in patients receiving CAPD
Previous
Next

Causes

  • Noncholera Vibrio infections are foodborne diseases that are largely associated with the following:
    • Consumption of raw or undercooked seafood such as oysters, clams, crabs, or mussels
    • Exposure of wound to contaminated water
  • Acute gastroenteritis associated with noncholera Vibrio infection is frequently self-limited, although persons with certain underlying medical conditions may develop fulminant infections. These underlying medical conditions include the following:
    • Advanced liver diseases, such as cirrhosis, hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, alcoholism, hemochromatosis, and liver transplantation
    • Hematologic diseases, such as acute leukemia, aplastic anemia, hemolytic anemia, and thalassemia
    • Immunosuppressive therapy, including cytotoxic chemotherapy, corticosteroids, and tacrolimus
    • Kidney disease involving kidney transplantation or hemodialysis
    • Miscellaneous procedures and conditions, including splenectomy and diabetes mellitus
Previous
 
 
Contributor Information and Disclosures
Author

Hoi Ho, MD  Associate Dean for Faculty Affairs and Development, Professor, Department of Internal Medicine, Director, Center for Advanced Teaching and Assessment in Clinical Simulation (ATACS), Paul L Foster School of Medicine, Texas Tech University Health Sciences Center; Consulting Physician, University Medical Center

Hoi Ho, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American College of Forensic Examiners, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Coauthor(s)

Ogechika Karl Alozie, MBBS, MPH, AAHIVS  Assistant Professor of Infectious Diseases, Department of Internal Medicine, Texas Tech University Health Sciences Center, Paul L Foster School Of Medicine

Ogechika Karl Alozie, MBBS, MPH, AAHIVS is a member of the following medical societies: American Academy of HIV Medicine

Disclosure: Nothing to disclose.

Sun-Yu Tran  Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine

Sun-Yu Tran is a member of the following medical societies: American College of Physicians and Texas Medical Association

Disclosure: Nothing to disclose.

Tony Tran Ho, MS  Texas Tech University School of Medicine

Tony Tran Ho, MS is a member of the following medical societies: American Medical Association and Texas Medical Association

Disclosure: Nothing to disclose.

Thong Huy Do, MD  Staff Physician, Department of Internal Medicine, Thomason Hospital, Texas Tech University

Thong Huy Do, MD is a member of the following medical societies: American College of Physicians

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary D Nettleman, MD, MS, MACP  Professor and Chair, Department of Medicine, Michigan State University College of Human Medicine

Mary D Nettleman, MD, MS, MACP is a member of the following medical societies: American College of Physicians, Association of Professors of Medicine, Central Society for Clinical Research, Infectious Diseases Society of America, and Society of General Internal Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Richard B Brown, MD, FACP  Chief, Division of Infectious Diseases, Baystate Medical Center; Professor, Department of Internal Medicine, Tufts University School of Medicine

Richard B Brown, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthor Wei-L Wu, MS, to the development and writing of this article.

References
  1. 2011 Estimates of foodborne illness in the united states. Available at http://www.cdc.gov/foodborneburden.

  2. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis. Jan 2011;17(1):7-15. [Medline].

  3. 3. Vital Signs: Incidence and Trends of Infection with Pathogens Transmitted Commonly Through Food --- Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 1996—2010. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6022a5.htm?s_cid=mm6022a5_w.

  4. Marano NN, Daniels NA, Easton AN, McShan A, Ray B, Wells JG. A survey of stool culturing practices for vibrio species at clinical laboratories in Gulf Coast states. J Clin Microbiol. Jun 2000;38(6):2267-70. [Medline].

  5. Dechet AM, Yu PA, Koram N, Painter J. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997-2006. Clin Infect Dis. Apr 1 2008;46(7):970-6. [Medline].

  6. Centers for Disease Control and Prevention (CDC). Vibrio illnesses after Hurricane Katrina--multiple states, August-September 2005. MMWR Morb Mortal Wkly Rep. Sep 23 2005;54(37):928-31. [Medline].

  7. Shapiro RL, Altekruse S, Hutwagner L. The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis. Sep 1998;178(3):752-9. [Medline].

  8. Brennt CE, Wright AC, Dutta SK. Growth of Vibrio vulnificus in serum from alcoholics: association with high transferrin iron saturation. J Infect Dis. Nov 1991;164(5):1030-2. [Medline].

  9. Hor LI, Chang TT, Wang ST. Survival of Vibrio vulnificus in whole blood from patients with chronic liver diseases: association with phagocytosis by neutrophils and serum ferritin levels. J Infect Dis. Jan 1999;179(1):275-8. [Medline].

  10. Miyoshi S, Nakazawa H, Kawata K, Tomochika K, Tobe K, Shinoda S. Characterization of the hemorrhagic reaction caused by Vibrio vulnificus metalloprotease, a member of the thermolysin family. Infect Immun. Oct 1998;66(10):4851-5. [Medline].

  11. Shao CP, Hor LI. Metalloprotease is not essential for Vibrio vulnificus virulence in mice. Infect Immun. Jun 2000;68(6):3569-73. [Medline].

  12. Hilton T, Rosche T, Froelich B, Smith B, Oliver J. Capsular polysaccharide phase variation in Vibrio vulnificus. Appl Environ Microbiol. Nov 2006;72(11):6986-93. [Medline].

  13. Lee SE, Kim SY, Kim CM, Kim MK, Kim YR, Jeong K. The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor. Infect Immun. Jun 2007;75(6):2795-801. [Medline].

  14. Wong TW, Wang YY, Sheu HM, Chuang YC. Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus. Antimicrob Agents Chemother. Mar 2005;49(3):895-902. [Medline].

  15. Shirai H, Ito H, Hirayama T, Nakamoto Y, Nakabayashi N, Kumagai K. Molecular epidemiologic evidence for association of thermostable direct hemolysin (TDH) and TDH-related hemolysin of Vibrio parahaemolyticus with gastroenteritis. Infect Immun. Nov 1990;58(11):3568-73. [Medline].

  16. Nishibuchi M, Fasano A, Russell RG, Kaper JB. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect Immun. Sep 1992;60(9):3539-45. [Medline].

  17. Vibrio parahaemolyticus infections associated with consumption of raw shellfish--three states, 2006. MMWR Morb Mortal Wkly Rep. Aug 11 2006;55(31):854-6. [Medline].

  18. Osaka K, Komatsuzaki M, Takahashi H, Sakano S, Okabe N. Vibrio vulnificus septicaemia in Japan: an estimated number of infections and physicians' knowledge of the syndrome. Epidemiol Infect. Oct 2004;132(5):993-6. [Medline].

  19. Haq SM, Dayal HH. Chronic liver disease and consumption of raw oysters: a potentially lethal combination--a review of Vibrio vulnificus septicemia. Am J Gastroenterol. May 2005;100(5):1195-9. [Medline].

  20. Liu JW, Lee IK, Tang HJ, Ko WC, Lee HC, Liu YC. Prognostic Factors and Antibiotics in Vibrio vulnificus Septicemia. Arch Intern Med. Oct 23 2006;166(19):2117-23. [Medline].

  21. Dadisman TA Jr, Nelson R, Molenda JR. Vibrio parahaemolyticus gastroenteritis in Maryland. I. Clinical and epidemiologic aspects. Am J Epidemiol. Dec 1972;96(6):414-26. [Medline].

  22. Howard RJ, Lieb S. Soft-tissue infections caused by halophilic marine vibrios. Arch Surg. Feb 1988;123(2):245-9. [Medline].

  23. Klontz KC, Lieb S, Schreiber M. Syndromes of Vibrio vulnificus infections. Clinical and epidemiologic features in Florida cases, 1981-1987. Ann Intern Med. Aug 15 1988;109(4):318-23. [Medline].

  24. Chuang YC, Ko WC, Wang ST, Liu JW, Kuo CF, Wu JJ. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother. Jun 1998;42(6):1319-22. [Medline].

  25. Anand RG, Lopez FA, deBoisblanc B. Vibrio vulnificus sepsis successfully treated with antibiotics, surgical debridement, and recombinant human activated protein C. J La State Med Soc. May-Jun 2004;156(3):130-3; quiz 133. [Medline].

  26. Mouzin E, Mascola L, Tormey MP. Prevention of Vibrio vulnificus infections. Assessment of regulatory educational strategies. JAMA. Aug 20 1997;278(7):576-8. [Medline].

  27. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--selected sites, United States, 2003. MMWR Morb Mortal Wkly Rep. Apr 30 2004;53(16):338-43. [Medline].

  28. Hiransuthikul N, Tantisiriwat W, Lertutsahakul K, Vibhagool A, Boonma P. Skin and soft-tissue infections among tsunami survivors in southern Thailand. Clin Infect Dis. Nov 15 2005;41(10):e93-6. [Medline].

  29. Hlady WG, Klontz KC. The epidemiology of Vibrio infections in Florida, 1981-1993. J Infect Dis. May 1996;173(5):1176-83. [Medline].

  30. Hollis DG, Weaver RE, Baker CN. Halophilic Vibrio species isolated from blood cultures. J Clin Microbiol. Apr 1976;3(4):425-31. [Medline].

  31. Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. Foodborne illness acquired in the United States--unspecified agents. Emerg Infect Dis. Jan 2011;17(1):16-22. [Medline].

  32. Summary of Notifiable Diseases in United States, 2009. Available at http://www.cdc.gov/mmwr/pdf/wk/mm5853.pdf.

Previous
Next
 
Vibrio infections. Early bullous lesions appear over the dorsum of the foot of a patient with cirrhosis.
Vibrio infections. In a patient with cirrhosis, skin lesion rapidly becomes necrotic.
Vibrio infections. Bullous lesions in a patient with cirrhosis continue to progress, and the patient rapidly develops hypotension and shock despite aggressive medical therapy.
Table 1. Noncholera Vibrio Species and Associated Clinical Presentations
Infection TypeNoncholera Vibrio SpeciesCytotoxins/Enzymes
GastroenteritisV parahaemolyticus



Non-01 V cholerae



Vibrio fluvialis



V mimicus



Vibrio furnissii



Vibrio hollisae



Vibrio alginolyticus



V vulnificus



Cytotoxin



Hemolysin



Wound infectionV alginolyticus



V vulnificus



Non-01 V cholerae



Vibrio damsela



Vibrio carchariae



V fluvialis



V parahaemolyticus



V mimicus



Protease



Hemolysin



Lipase



DNAase



Cytolysin



SepticemiaV vulnificus



V fluvialis



V damsela



Non-01 V cholerae



Vibrio cincinnatiensis



Proteases



Endotoxic lipopolysaccharide



Table 2. Clinical Presentation Rates of Pathogenic Vibrio Infections
Vibrio SpeciesGastroenteritis



(%)



Wound Infection



(%)



Septicemia



(%)



Miscellaneous



(%)



V parahaemolyticus593452
V vulnificus545437
Non-01 V cholerae67915
V alginolyticus5-1271110-15
V mimicus8533
V fluvialis73106
V damselaRare>95Rare
V furnissii>90RareRare
Vibrio metschnikoviiCommonRareRare
V hollisae8575
V cincinnatiensisRareRareRareMeningitis
Table 3. Clinical Signs and Symptoms of Vibrio Infections
Clinical PresentationSymptoms (Frequency)
GastroenteritisDiarrhea (100%)



Abdominal cramps (89%)



Nausea (76%)



Vomiting (55%)



Fever (47%)



Bloody stools (29%)



Headache (24%)



Myalgia (24%)



Wound infectionSwelling (100%)



Pain (100%)



Erythema (100%)



Bullae (30-50%)



Necrosis (30-50%)



Gangrene (< 10%)



SepticemiaFever (>90%)



Hypothermia (< 10%)



Hypotension (100%)



Tachycardia (80-90%)



Shock (50-70%)



Bullae (80-100%)



Acute respiratory distress syndrome (< 5%)



Multiple organ dysfunction (30-50%)



Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.